Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Healthcare venture capital?Bydureon cost canada?Methylphenidate drug class?Ketorolac tromethamine dispersible tablets 10 mg price?Azelastine hydrochloride nasal spray?
See the DrugPatentWatch profile for voquezna
Voquezna (vonoprazan) is a relatively new prescription medicine. It has been on the U.S. market only since its approval by the FDA in 2022, so the time on the market is measured from that point onward.
Voquezna received FDA approval in 2022, which is the key date for when it began commercial availability in the U.S. [1]
Because “on the market” can mean approval vs. actual product launch, the safest way to track duration is: - From FDA approval year (2022) for an approval-based measure. [1] - From the first widely available launch/first sales date if you need a tighter timeline (those details aren’t provided in the source here).
If you need the exact number of months to a particular day, confirm whether you mean: - FDA approval date (2022), or - the first distribution/launch date reported by the manufacturer or industry trackers. Sources [1] DrugPatentWatch.com – Voquezna (vonoprazan) information
Other Questions About Voquezna :